Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
After finishing at $610.86 in the prior trading day, Regeneron Pharmaceuticals, Inc (NASDAQ: REGN) closed at $568.91, down -6.87%. In other words, the price has decreased by -$6.87 from its previous closing price. On the day, 2.62 million shares were traded.
Ratios:
Our goal is to gain a better understanding of REGN by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.87 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 16.89. For the most recent quarter (mrq), Quick Ratio is recorded 3.95 and its Current Ratio is at 4.73. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.10.
On February 05, 2025, Leerink Partners Upgraded its rating to Outperform which previously was Market Perform and also upped its target price recommendation from $762 to $834.
UBS Downgraded its Buy to Neutral on January 16, 2025, whereas the target price for the stock was revised from $1130 to $738.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 01 ’24 when McCourt Marion sold 1,000 shares for $844.61 per share. The transaction valued at 844,610 led to the insider holds 12,931 shares of the business.
MARION E MCCOURT bought 1,000 shares of REGN for $844,610 on Nov 01 ’24. On Oct 01 ’24, another insider, RYAN ARTHUR F, who serves as the Director of the company, sold 100 shares for $1048.78 each. As a result, the insider received 104,878 and left with 17,582 shares of the company.
Valuation Measures:
As of this moment, Regeneron’s Price-to-Earnings (P/E) ratio for their current fiscal year is 14.86, and their Forward P/E ratio for the next fiscal year is 14.09. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 6.38. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.36 while its Price-to-Book (P/B) ratio in mrq is 2.12.
Stock Price History:
Over the past 52 weeks, REGN has reached a high of $1211.20, while it has fallen to a 52-week low of $525.99. The 50-Day Moving Average of the stock is -11.20%, while the 200-Day Moving Average is calculated to be -32.82%.
Shares Statistics:
A total of 107.80M shares are outstanding, with a floating share count of 104.85M. Insiders hold about 3.60% of the company’s shares, while institutions hold 87.24% stake in the company.
